{"altmetric_id":1903252,"counts":{"readers":{"mendeley":5,"citeulike":2,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["IJGConline","_Ovarian_C_News"],"posts_count":4}},"citation":{"abstract":"Phase 2 trials suggest that prolonged intravenous (IV) infusion of the topoisomerase 1 inhibitor topotecan may be less toxic than when given by standard IV bolus 5-day administration. Oxaliplatin exhibits efficacy in platinum-pretreated disease and shows preclinical synergy with topoisomerase 1 inhibitors. We sought to determine the efficacy and safety of oxaliplatin plus infusion topotecan in recurrent platinum-pretreated ovarian cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa61d3cf058f6100078c8","doi":"10.1097\/igc.0b013e3182a809e0","first_seen_on":"2013-11-13T17:50:31+00:00","funders":["nci"],"issns":["1048-891X"],"issue":"9","journal":"International Journal of Gynecological Cancer","last_mentioned_on":1385339817,"links":["http:\/\/journals.lww.com\/ijgc\/Abstract\/2013\/11000\/A_Phase_2_Study_of_Oxaliplatin_Combined_With.7.aspx","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24172094"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/ijgc\/2013\/11000\/A_Phase_2_Study_of_Oxaliplatin_Combined_With.7.pdf","pmid":"24172094","pubdate":"2013-11-01T00:00:00+00:00","publisher":"Lippincott Williams and Wilkins (530 Walnut Street,P O Box 327, Philadelphia PA 19106-3621, United States)","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1577","subjects":["neoplasms","gynecology"],"title":"A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer","type":"article","volume":"23","mendeley_url":"http:\/\/www.mendeley.com\/research\/phase-2-study-oxaliplatin-combined-continuous-infusion-topotecan-patients-previously-treated-ovarian"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4507509,"mean":5.1386389830674,"rank":3066876,"this_scored_higher_than_pct":20,"this_scored_higher_than":944851,"rank_type":"exact","sample_size":4507509,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":102749,"mean":7.7173791995953,"rank":68561,"this_scored_higher_than_pct":21,"this_scored_higher_than":21671,"rank_type":"exact","sample_size":102749,"percentile":21},"this_journal":{"total_number_of_other_articles":1355,"mean":0.97480502215657,"rank":565,"this_scored_higher_than_pct":52,"this_scored_higher_than":716,"rank_type":"exact","sample_size":1355,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":77,"mean":0.72697368421053,"rank":30,"this_scored_higher_than_pct":49,"this_scored_higher_than":38,"rank_type":"exact","sample_size":77,"percentile":49}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":1,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Student  > Master":2},"by_discipline":{"Medicine and Dentistry":3,"Agricultural and Biological Sciences":1,"Unspecified":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/IJGConline\/status\/401678122455560193","license":"public","citation_ids":[1903252],"posted_on":"2013-11-16T11:48:21+00:00","author":{"name":"IJGC","url":"http:\/\/ijgc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/756209106717777920\/fvbA4WtA_normal.jpg","description":"IJGC is the primary publication for detection, prevention, diagnosis, and treatment of gynecologic malignancies. Emphasizes a multidisciplinary approach.","id_on_source":"IJGConline","tweeter_id":"174787278","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"401678122455560193"},{"url":"http:\/\/twitter.com\/_Ovarian_C_News\/status\/404663586271686656","license":"datasift","citation_ids":[1903252],"posted_on":"2013-11-24T17:31:31+00:00","author":{"name":"_Ovarian_Cancer","image":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_4_normal.png","description":"","id_on_source":"_Ovarian_C_News","tweeter_id":"2167254044","followers":2},"tweet_id":"404663586271686656"},{"url":"http:\/\/twitter.com\/_Ovarian_C_News\/status\/404770648297193472","license":"public","citation_ids":[1903252],"posted_on":"2013-11-25T00:36:57+00:00","author":{"name":"_Ovarian_Cancer","image":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_4_normal.png","description":"","id_on_source":"_Ovarian_C_News","tweeter_id":"2167254044","followers":2},"tweet_id":"404770648297193472"},{"url":"http:\/\/twitter.com\/IJGConline\/status\/400682033027883008","license":"public","citation_ids":[1903252],"posted_on":"2013-11-13T17:50:15+00:00","author":{"name":"IJGC","url":"http:\/\/ijgc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/756209106717777920\/fvbA4WtA_normal.jpg","description":"IJGC is the primary publication for detection, prevention, diagnosis, and treatment of gynecologic malignancies. Emphasizes a multidisciplinary approach.","id_on_source":"IJGConline","tweeter_id":"174787278","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"400682033027883008"}]}}